Bendazac
From Wikipedia, the free encyclopedia
![]() |
|
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration |
Topical |
ATC code | M02AA11 (WHO) S01BC07 (WHO) |
Identifiers | |
|
|
CAS Number | 20187-55-7 ![]() |
PubChem (CID) | 2313 |
ChemSpider | 2223 ![]() |
UNII | G4AG71204O ![]() |
KEGG | D01594 ![]() |
ChEBI | CHEBI:31257 ![]() |
ChEMBL | CHEMBL1089221 ![]() |
ECHA InfoCard | 100.039.594 |
Chemical and physical data | |
Formula | C16H14N2O3 |
Molar mass | 282.294 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
![]() ![]() |
Bendazac (or bendazolic acid) is a non-steroidal anti-inflammatory drug used for joint and muscular pain.
Synthesis[edit]
Principal action is inhibition of protein denaturation.
![](http://web.archive.org./web/20170206091810im_/https://upload.wikimedia.org/wikipedia/commons/thumb/3/34/Bendazac_synthesis.svg/700px-Bendazac_synthesis.svg.png)
Bendazac synthesis: BE 699226; G. Palazzo, U.S. Patent 3,470,194 (1967, 1969 both to Francesco Angelini).
Use of chloroacetamide in the alkylation step, followed by acid hydrolysis produces bendazac (instead of benzydamine).
See also[edit]
References[edit]
![]() |
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |
![]() |
This analgesic-related article is a stub. You can help Wikipedia by expanding it. |